Clinical Trial Update: Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating almonertinib with or without chemotherapy as adjuvant treatment after complete tumor resection in stage II-IIIA non-small cell lung car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Non-small Cell Lung Carcinoma | Phase 3 | Status: ENROLLING_BY_INVITATION